alendronate and trolamine salicylate

alendronate has been researched along with trolamine salicylate in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (62.50)	29.6817
2010's	3 (37.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, EB; Goater, JJ; Lu, AP; Mollano, AV; Okeefe, RJ; Puzas, JE; Rosier, RN; Schwarz, EM	1
Goto, H; Imanishi, Y; Inaba, M; Inui, K; Kobayashi, K; Kumeda, Y; Nishizawa, Y; Okada, F	1
Gerster, JH	1
Brixen, KT; Frederiksen, L; Junker, P	1
Gwynne Jones, DP; Highton, J; Savage, RL	1
Fett, N; Liu, RH	1
Alcaraz, MJ; Caeiro, JR; Ferrándiz, ML; Guede, D; Ibáñez, L; Maicas, N; Motterlini, R	1
Uğurlar, M	1

Reviews

1 review(s) available for alendronate and trolamine salicylate

Article	Year
Multicentric reticulohistiocytosis with dermatomyositis-like features: a more common disease presentation than previously thought. Dermatology (Basel, Switzerland), 2011, Volume: 222, Issue:2 Topics: Alendronate; Antineoplastic Protocols; Arthritis; Breast Neoplasms; Combined Modality Therapy; Dermatologic Agents; Dermatomyositis; Diagnosis, Differential; Drug Therapy, Combination; Female; Histiocytosis; Humans; Lymphatic Metastasis; Mediastinal Neoplasms; Methotrexate; Middle Aged; Prednisone	2011

Article

Year

Multicentric reticulohistiocytosis with dermatomyositis-like features: a more common disease presentation than previously thought.

Dermatology (Basel, Switzerland), 2011, Volume: 222, Issue:2

Topics: Alendronate; Antineoplastic Protocols; Arthritis; Breast Neoplasms; Combined Modality Therapy; Dermatologic Agents; Dermatomyositis; Diagnosis, Differential; Drug Therapy, Combination; Female; Histiocytosis; Humans; Lymphatic Metastasis; Mediastinal Neoplasms; Methotrexate; Middle Aged; Prednisone

2011

Other Studies

7 other study(ies) available for alendronate and trolamine salicylate

Article	Year
Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2000, Volume: 18, Issue:6 Topics: Alendronate; Animals; Arthritis; Arthroplasty; Cell Division; Disease Models, Animal; Female; Male; Mice; Mice, Inbred CBA; Osteoclasts; Osteolysis; Pentoxifylline; Postoperative Complications; Prostheses and Implants; Skull; Stress, Mechanical; Tumor Necrosis Factor-alpha	2000
Successful treatment of multicentric reticulohistiocytosis with alendronate: evidence for a direct effect of bisphosphonate on histiocytes. Arthritis and rheumatism, 2003, Volume: 48, Issue:12 Topics: Adult; Alendronate; Arthritis; Female; Histiocytes; Histiocytosis, Non-Langerhans-Cell; Humans; Skin Diseases	2003
Acute polyarthritis related to once-weekly alendronate in a woman with osteoporosis. The Journal of rheumatology, 2004, Volume: 31, Issue:4 Topics: Acute Disease; Alendronate; Arthralgia; Arthritis; Drug Administration Schedule; Female; Humans; Joints; Middle Aged; Muscular Diseases; Osteoporosis, Postmenopausal; Pain	2004
[Persistent polyarticular synovitis after treatment with alendronate]. Ugeskrift for laeger, 2007, Apr-23, Volume: 169, Issue:17 Topics: Alendronate; Arthritis; Bone Density Conservation Agents; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Synovitis	2007
Alendronate-induced synovitis. The Journal of rheumatology, 2008, Volume: 35, Issue:3 Topics: Aged; Alendronate; Arthritis; Bone Density Conservation Agents; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Registries; Synovitis	2008
Downregulation of the inflammatory response by CORM-3 results in protective effects in a model of postmenopausal arthritis. Calcified tissue international, 2012, Volume: 91, Issue:1 Topics: Alendronate; Animals; Anti-Inflammatory Agents; Arthritis; Biomarkers; Disease Models, Animal; Down-Regulation; Female; Humans; Inflammation; Mice; Mice, Inbred DBA; Organometallic Compounds; Osteoporosis, Postmenopausal	2012
Alendronate- and risedronate-induced acute polyarthritis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2016, Volume: 27, Issue:11 Topics: Alendronate; Arthritis; Bone Density Conservation Agents; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Risedronic Acid	2016